However, MCT4 mRNA levels are higher than those of MCT1, suggesting a high and continued glycolytic activity of AML blasts (Figure 3B), particularly in AML pertaining to the M4 and M5 subtypes, as compared to CD34+ HPCs. Here, CD34 is linked to acute myeloid leukemia.